USD 0.47
(-20.74%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 15.39 Million USD | -5.89% |
2022 | 16.35 Million USD | 5.77% |
2021 | 15.46 Million USD | -9.31% |
2020 | 17.05 Million USD | 23.36% |
2019 | 13.82 Million USD | 84.66% |
2018 | 7.48 Million USD | -83.27% |
2017 | 44.74 Million USD | 8.37% |
2016 | 41.28 Million USD | 39.65% |
2015 | 29.56 Million USD | 1.76% |
2014 | 29.05 Million USD | -14.0% |
2013 | 33.78 Million USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 5.75 Million USD | -65.63% |
2024 Q1 | 16.74 Million USD | 8.75% |
2023 Q2 | 16.86 Million USD | 1.57% |
2023 FY | 15.39 Million USD | -5.89% |
2023 Q1 | 16.6 Million USD | 1.47% |
2023 Q4 | 15.39 Million USD | 1.43% |
2023 Q3 | 15.17 Million USD | -9.98% |
2022 Q4 | 16.35 Million USD | 1.5% |
2022 Q3 | 16.11 Million USD | 1.47% |
2022 FY | 16.35 Million USD | 5.77% |
2022 Q1 | 15.66 Million USD | 1.3% |
2022 Q2 | 15.88 Million USD | 1.38% |
2021 Q2 | 15.06 Million USD | -12.6% |
2021 Q3 | 15.26 Million USD | 1.31% |
2021 Q4 | 15.46 Million USD | 1.34% |
2021 FY | 15.46 Million USD | -9.31% |
2021 Q1 | 17.23 Million USD | 1.07% |
2020 Q1 | 14.02 Million USD | 1.48% |
2020 Q4 | 17.05 Million USD | 1.43% |
2020 Q3 | 16.81 Million USD | 1.42% |
2020 FY | 17.05 Million USD | 23.36% |
2020 Q2 | 16.57 Million USD | 18.16% |
2019 Q1 | 9.15 Million USD | 22.23% |
2019 Q2 | 13.79 Million USD | 50.79% |
2019 Q4 | 13.82 Million USD | 0.39% |
2019 Q3 | 13.77 Million USD | -0.2% |
2019 FY | 13.82 Million USD | 84.66% |
2018 Q1 | 7.52 Million USD | -83.19% |
2018 FY | 7.48 Million USD | -83.27% |
2018 Q4 | 7.48 Million USD | -8.1% |
2018 Q3 | 8.14 Million USD | 4.13% |
2018 Q2 | 7.82 Million USD | 4.02% |
2017 Q3 | 43.28 Million USD | 1.89% |
2017 FY | 44.74 Million USD | 8.37% |
2017 Q4 | 44.74 Million USD | 3.36% |
2017 Q2 | 42.48 Million USD | 1.44% |
2017 Q1 | 41.88 Million USD | 1.44% |
2016 Q1 | 29.97 Million USD | 1.39% |
2016 Q3 | 40.71 Million USD | 1.42% |
2016 Q2 | 40.14 Million USD | 33.91% |
2016 Q4 | 41.28 Million USD | 1.41% |
2016 FY | 41.28 Million USD | 39.65% |
2015 FY | 29.56 Million USD | 1.76% |
2015 Q1 | 29.55 Million USD | 1.73% |
2015 Q2 | 29.99 Million USD | 1.48% |
2015 Q4 | 29.56 Million USD | 1.41% |
2015 Q3 | 29.15 Million USD | -2.8% |
2014 Q2 | 39.66 Million USD | 0.0% |
2014 FY | 29.05 Million USD | -14.0% |
2014 Q4 | 29.05 Million USD | -11.26% |
2014 Q1 | - USD | -100.0% |
2014 Q3 | 32.73 Million USD | -17.45% |
2013 FY | 33.78 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | 33.78 Million USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | 82.037% |
AngioDynamics, Inc. | 5.91 Million USD | -160.315% |
AtriCure, Inc. | 74.49 Million USD | 79.334% |
Azenta, Inc. | 60.43 Million USD | 74.527% |
BioLife Solutions, Inc. | 42.69 Million USD | 63.939% |
The Cooper Companies, Inc. | 2.56 Billion USD | 99.401% |
Daxor Corporation | 755.65 Thousand USD | -1937.295% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -114.774% |
Femasys Inc. | 6.7 Million USD | -129.746% |
GlucoTrack, Inc. | 196 Thousand USD | -7754.592% |
Harvard Bioscience, Inc. | 42.77 Million USD | 64.008% |
Hologic, Inc. | 2.53 Billion USD | 99.393% |
ICU Medical, Inc. | 1.7 Billion USD | 99.097% |
Intuitive Surgical, Inc. | 89.8 Million USD | 82.856% |
KORU Medical Systems, Inc. | 4.44 Million USD | -246.335% |
LeMaitre Vascular, Inc. | 19.09 Million USD | 19.377% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 98.413% |
Microbot Medical Inc. | 231 Thousand USD | -6564.502% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -109.995% |
Merit Medical Systems, Inc. | 891.35 Million USD | 98.273% |
Nephros, Inc. | 1.83 Million USD | -738.508% |
NovoCure Limited | 596.24 Million USD | 97.418% |
NEXGEL, Inc. | 2.79 Million USD | -450.214% |
NEXGEL, Inc. | 2.79 Million USD | -450.214% |
Singular Genomics Systems, Inc. | 75.28 Million USD | 79.552% |
OraSure Technologies, Inc. | 13.5 Million USD | -14.003% |
Pro-Dex, Inc. | 13.54 Million USD | -13.641% |
Pulse Biosciences, Inc. | 9.14 Million USD | -68.362% |
Predictive Oncology Inc. | 2.85 Million USD | -438.887% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -348.251% |
QuidelOrtho Corporation | 2.61 Billion USD | 99.411% |
Repligen Corporation | 711.8 Million USD | 97.837% |
Sanara MedTech Inc. | 11.79 Million USD | -30.553% |
STAAR Surgical Company | 35.83 Million USD | 57.038% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -4401.462% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.33% |
Jin Medical International Ltd. | 4.11 Million USD | -274.301% |